Brief: Johnson & Johnson Reports 10.2% Passive Stake In Nanobiotix SA As Of Nov 9 - SEC Filing
Nov 16 (Reuters) - Johnson & Johnson JNJ.N :
* JOHNSON & JOHNSON REPORTS 10.2% PASSIVE STAKE IN
NANOBIOTIX SA
AS OF NOVEMBER 9 - SEC FILING
Further company coverage: JNJ.N
((reuters.briefs@thomsonreuters.com;))
Recent news on Nanobiotix SA
See all newsBrief: Nanobiotix S.A. H1 Net Income EUR -34.3 Million
France's Nanobiotix H1 net loss widens on lower revenue, absence of 2025 one-off gain
Brief: Nanobiotix Reports Encouraging Full Phase 1 Results For Lung Cancer Drug JNJ-1900
Brief: Nanobiotix Q1 Cash And Cash Equivalents Of €42.1 Mln
Brief: NANOBIOTIX Announces Closing Of Global Offering